CRESCITA THERAPEUTICS INC (CTX.CA) Stock Price, Quote, News and Overview
TSX:CTX - Toronto Stock Exchange - CA2258471028 - Common Stock - Currency: CAD
CTX.CA Quote, Performance and Key Statistics
TSX:CTX (3/6/2025, 7:00:00 PM)
0.55
-0.04 (-6.78%)
The current stock price of CTX.CA is 0.55 CAD. In the past month the price decreased by -6.78%. In the past year, price increased by 19.57%.
CTX.CA Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| BHC.CA | BAUSCH HEALTH COS INC | 1.87 | 3.77B | ||
| CRON.CA | CRONOS GROUP INC | N/A | 1.08B | ||
| TLRY.CA | TILRAY BRANDS INC | N/A | 928.28M | ||
| DHT-UN.CA | DRI HEALTHCARE TRUST | 4.93 | 675.16M | ||
| GUD.CA | KNIGHT THERAPEUTICS INC | N/A | 546.47M | ||
| DHT-U.CA | DRI HEALTHCARE TRUST | 3.62 | 495.53M | ||
| ACB.CA | AURORA CANNABIS INC | N/A | 376.34M | ||
| WEED.CA | CANOPY GROWTH CORP | N/A | 293.01M | ||
| CPH.CA | CIPHER PHARMACEUTICALS INC | 12.54 | 288.91M | ||
| HITI.CA | HIGH TIDE INC | N/A | 278.36M | ||
| TSND.CA | TERRASCEND CORP | N/A | 249.63M | ||
| NGEN.CA | NERVGEN PHARMA CORP | N/A | 198.02M |
Related stock screener links
About CTX.CA
Company Profile
Crescita Therapeutics, Inc. engages in the provision of non-prescription skincare products. The company is headquartered in Laval, Quebec and currently employs 80 full-time employees. The company went IPO on 2016-03-07. The company offers a portfolio of science-based non-prescription skincare products and early to commercial stage prescription products. The company operates in three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The Commercial Skincare segment manufactures and sells branded non-prescription skincare products for the Canadian and international markets. The company also commercializes Pliaglis, NCTF Boost 135 HA, ART FILLER, and Obagi Medical in Canada. The Licensing and Royalties segment engaged in licensing the intellectual property related to Pliaglis or its transdermal delivery technologies. Manufacturing and Services segment engaged in the sale of topical products manufactured to client specifications under the Company’s contract development and manufacturing organization infrastructure, and product development services.
Company Info
CRESCITA THERAPEUTICS INC
2805, Place Louis R Renaud
Laval QUEBEC H7V 0A3 CA
CEO: Serge Verreault
Employees: 62
Company Website: https://www.crescitatherapeutics.com/
Investor Relations: http://www.crescitatherapeutics.com/investors
Phone: 18003610352
CRESCITA THERAPEUTICS INC / CTX.CA FAQ
What is the stock price of CRESCITA THERAPEUTICS INC today?
The current stock price of CTX.CA is 0.55 CAD. The price decreased by -6.78% in the last trading session.
What is the ticker symbol for CRESCITA THERAPEUTICS INC stock?
The exchange symbol of CRESCITA THERAPEUTICS INC is CTX and it is listed on the Toronto Stock Exchange exchange.
On which exchange is CTX.CA stock listed?
CTX.CA stock is listed on the Toronto Stock Exchange exchange.
What is CRESCITA THERAPEUTICS INC worth?
CRESCITA THERAPEUTICS INC (CTX.CA) has a market capitalization of 10.48M CAD. This makes CTX.CA a Nano Cap stock.
How many employees does CRESCITA THERAPEUTICS INC have?
CRESCITA THERAPEUTICS INC (CTX.CA) currently has 62 employees.
What are the support and resistance levels for CRESCITA THERAPEUTICS INC (CTX.CA) stock?
CRESCITA THERAPEUTICS INC (CTX.CA) has a support level at 0.54 and a resistance level at 0.55. Check the full technical report for a detailed analysis of CTX.CA support and resistance levels.
Should I buy CRESCITA THERAPEUTICS INC (CTX.CA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of CTX.CA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of CTX.CA, evaluating the profitability, health, valuation and growth aspects
- CRESCITA THERAPEUTICS INC (CTX.CA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- CRESCITA THERAPEUTICS INC (CTX.CA) Sales and EPS estimates to see what analysts future expectations are.
- CRESCITA THERAPEUTICS INC (CTX.CA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- CRESCITA THERAPEUTICS INC (CTX.CA) Insider and Institutional Ownership to learn about the owners and their transactions.
- CRESCITA THERAPEUTICS INC (CTX.CA) Stock Chart to make your own analysis
- CRESCITA THERAPEUTICS INC (CTX.CA) Latest news and press-releases to stay up to date.
Does CRESCITA THERAPEUTICS INC (CTX.CA) stock pay dividends?
CTX.CA does not pay a dividend.
When does CRESCITA THERAPEUTICS INC (CTX.CA) report earnings?
CRESCITA THERAPEUTICS INC (CTX.CA) will report earnings on 2025-03-19.
What is the Price/Earnings (PE) ratio of CRESCITA THERAPEUTICS INC (CTX.CA)?
CRESCITA THERAPEUTICS INC (CTX.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.14).
CTX.CA Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to CTX.CA. When comparing the yearly performance of all stocks, CTX.CA is one of the better performing stocks in the market, outperforming 71.23% of all stocks.
CTX.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to CTX.CA. While CTX.CA seems to be doing ok healthwise, there are quite some concerns on its profitability.
CTX.CA Financial Highlights
Over the last trailing twelve months CTX.CA reported a non-GAAP Earnings per Share(EPS) of -0.14. The EPS decreased by -369.67% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -12.07% | ||
| ROE | -17.05% | ||
| Debt/Equity | 0.03 |